Singapore
Singapore's Great Eastern, health firm Doctor Anywhere bolster venture
The latter has been providing health service to group insurance clients since 2019.
Singapore's Great Eastern, health firm Doctor Anywhere bolster venture
The latter has been providing health service to group insurance clients since 2019.
Singapore's healthcare-related stocks averaged 37% gains in YTD 2020
They made it to the city’s top 200 stocks by daily turnover.
Telemedicine platform activity surges across Asia Pacific
It has been receiving government support as a way to control the spread of the pandemic.
HC Surgical shareholder blames CEO for breach of duty
This was related to the hiking of its stake in Julian Ong Endoscopy & Surgery.
NOVI Health brings holistic approach to lifestyle-based illnesses
Its team of medical specialists, dietitians, and fitness coaches offers lifestyle interventions.
Pharma sector records 16.6% QoQ growth
Total market cap of top companies declined 11.4% QoQ.
Find out who won at this year's Healthcare Asia Awards
The event was held via video conferencing throughout the week of 14-17 April.
Singapore-listed ISEC Healthcare's profit fell 37% to $974,680m in Q1
This was mainly attributed to a fall in business activities in Malaysia.
Doctor Anywhere rolls out teleconsultation for suspected COVID-19 cases
The public fees for video consultations is at $7.01.
Singapore's HC Surgical buys control stake in endoscopy business for $536,060
It plans to buy the remaining stake at a later stage.
Oliver Healthcare Packaging clinches Packaging Design of the Year Award
Its pioneering Dispos-a-vent® Barrier Pouch improves sterility and lowers costs for medical device manufacturers.
Femto Research grabs Service Innovation of the Year at Healthcare Asia Awards
The company’s Saliva p53Microbiome can identify and monitor various cancers and suitably replace blood samples.
National Cardiovascular Center Harapan Kita clinches three awards at Healthcare Asia Awards 2020
The hospital won awards for patient care, service delivery innovation and providing specialty services.
Travel restrictions weigh on IHH Healthcare Q2 earnings
The lack of new foreign patients would mean a near-zero patient revenue for its Singapore unit.
Asia-Pacific healthtech funding plunged 56% to $703m in Q1
Half of the clusters that outperformed the ecosystem were relevant to addressing COVID-19.
Medtech firm Biolidics allowed to sell COVID-19 test kit in EU
This followed after the test kit was allowed to be sold in Singapore and the Philippines.
Singapore-based Doctor Anywhere bags $27m Series B funding
It plans to expand its platform to more markets this year.